| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |